KassnerARobertsTTaylorKSilverFMikulisD:
Prediction of hemorrhage in acute ischemic stroke using permeability MR
imaging. Am J Neuroradiol2005); 26:
2213–17.
2.
de CamargoSa ECKoroshetzWJ:
Neuroimaging of ischemia and infarction.
NeuroRX2005); 2:
265–76.
3.
WuOKoroshetzWJOstergaardL.
Predicting tissue outcome in acute human cerebral ischemia using combined
diffusion- and perfusion weighted MR imaging. Stroke2001); 32:
933–42.
4.
SobeskyJWeberZaro OLehnhardtFG.
Does the mismatch match the penumbra?: Magnetic resonance imaging and
positron emission tomography in early ischemic stroke.
Stroke2005); 36:
908–85.
5.
ButcherKSParsonsMMacGregorL.
Refining the perfusion–diffusion mismatch hypothesis.
Stroke2005); 36:
1153–9.
6.
SchaeferPWRoccatagliataLLedezmaC.
First-pass quantitative CT perfusion identifies thresholds for
salvageable penumbra in acute stroke patients treated with intra-arterial
therapy. Am J Neuroradiol2006); 27:
20–5.
7.
WintermarkMFlandersAEVelthuisB.
Perfusion-CT assessment of infarct core and penumbra: Receiver operating
characteristic curve analysis in 130 patients suspected of acute hemispheric
stroke. Stroke2006); 37:
979–85.
8.
GuadagnoJVWarburtonEAAigbirhioFI.
Does the acute diffusion-weighted imaging lesion represent the penumbra
as well as core? A combined quantitative PET/MRI voxel-based study.
J Cereb Blood Flow Metab2004); 24:
1249–54.
9.
DavisSMDonnanGAButcherKSParsonsM:
Selection of thrombolytic therapy beyond 3 h using magnetic resonance
imaging. Curr Opin Neurol2005); 18:
47–52.
10.
HackeWAlbersGAl-RawiY.
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II
MRI-based 9-hour window acute stroke thrombolysis trial with intravenous
desmoteplase. Stroke2005); 36:
66–73.
